Varex Imaging (VREX) Stock: Buy, Sell, or Hold?
VREX - Varex Imaging Corporation Common Stock
$18.46
-0.03 (-0.16%)
âŧ
5d:
+0.05%
30d:
-0.05%
90d:
+71.88%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 17, 2026
Get Alerted When VREX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: VREX is fairly priced but lacks strong directional signals. At 10.8% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: VREX is fairly priced but lacks strong directional signals. At 10.8% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.46
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.43
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VREX is currently trading at $18.46, which is considered slightly low relative to its 30-day fair value range of $18.46 to $18.50. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.2) compared to its historical average (12.7). At these levels, the market is pricing in 10.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, VREX is in a strong uptrend. The price is currently testing key support at $18.42. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VREX is in a strong uptrend. The price is currently testing key support at $18.42. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$18.46 -
$18.50
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($18.90)
- NEUTRAL: PE elevated vs history but 10.8% growth expectation is conservative given 453% recent growth
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$18.46 -
$18.50
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$18.42
Resistance Level
$18.51
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.25
Wall Street Target
$18.90
(+2.4%)
Revenue Growth (YoY)
3.7%
Earnings Growth (YoY)
453.4%
Profit Margin
2.6%
Valuation Premium vs History
+10.8% premium
PE vs Historical
17.3 vs 12.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.8%
(market-implied from PE analysis)
1-Year Target
$20.45
(+11%)
2-Year Target
$22.66
(+23%)
3-Year Target
$25.11
(+36%)
3-Yr Target (if PE normalizes)
(PE: 17â13)
PE COMPRESSION
$18.48
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 27.4%)
$45.12
(+144%)
Base:
(SPY PE: 17.3, Growth: 27.4%)
$38.15
(+107%)
Bear:
(PE: 12.7, Growth: 27.4%)
$28.09
(+52%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 34.89 | Current EPS (TTM): $0.53
Bull Case
$40.68
(+120%)
Analyst growth 100.0%, PE expands to 38.4
Base Case
$36.98
(+100%)
Market implied 100.0%, PE stable at 34.9
Bear Case
$12.57
(-32%)
Severe decline -20.0%, PE contracts to 29.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 02, 2026 7:18 PM ET
Data refreshes hourly during market hours. Next update: 8:18 PM
Data refreshes hourly during market hours. Next update: 8:18 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VREX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 58 HOLD |
